DK475483D0 - Hydratiserede,lagdelte lipidfaser samt fremgangsmade til fremstilling af en homogeniseret suspension heraf - Google Patents
Hydratiserede,lagdelte lipidfaser samt fremgangsmade til fremstilling af en homogeniseret suspension herafInfo
- Publication number
- DK475483D0 DK475483D0 DK4754/83A DK475483A DK475483D0 DK 475483 D0 DK475483 D0 DK 475483D0 DK 4754/83 A DK4754/83 A DK 4754/83A DK 475483 A DK475483 A DK 475483A DK 475483 D0 DK475483 D0 DK 475483D0
- Authority
- DK
- Denmark
- Prior art keywords
- hydratized
- procedures
- preparing
- dispersion
- orifice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/44—Mixers in which the components are pressed through slits
- B01F25/441—Mixers in which the components are pressed through slits characterised by the configuration of the surfaces forming the slits
- B01F25/4413—Mixers in which the components are pressed through slits characterised by the configuration of the surfaces forming the slits the slits being formed between opposed conical or cylindrical surfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/44—Mixers in which the components are pressed through slits
- B01F25/442—Mixers in which the components are pressed through slits characterised by the relative position of the surfaces during operation
- B01F25/4422—Mixers in which the components are pressed through slits characterised by the relative position of the surfaces during operation the surfaces being maintained in a fixed but adjustable position, spaced from each other, therefore allowing the slit spacing to be varied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system
- Y10S516/929—Specified combination of agitation steps, e.g. mixing to make subcombination composition followed by homogenization
- Y10S516/93—Low shear followed by high shear
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
- Y10S977/783—Organic host/matrix, e.g. lipid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Steroid Compounds (AREA)
- Polymerisation Methods In General (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8217311A FR2534487B1 (fr) | 1982-10-15 | 1982-10-15 | Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede |
FR8217311 | 1982-10-15 |
Publications (4)
Publication Number | Publication Date |
---|---|
DK475483D0 true DK475483D0 (da) | 1983-10-14 |
DK475483A DK475483A (da) | 1984-04-16 |
DK159194B DK159194B (da) | 1990-09-17 |
DK159194C DK159194C (da) | 1991-02-25 |
Family
ID=9278316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK475483A DK159194C (da) | 1982-10-15 | 1983-10-14 | Fremgangsmaade til fremstilling af en homogeniseret dispersion af en vandholdig, lamellar lipidfase i en vaeske |
Country Status (12)
Country | Link |
---|---|
US (1) | US4621023A (da) |
EP (1) | EP0107559B2 (da) |
JP (1) | JPS5989620A (da) |
AT (1) | ATE27909T1 (da) |
CA (1) | CA1228779A (da) |
DE (2) | DE3372174D1 (da) |
DK (1) | DK159194C (da) |
ES (1) | ES526498A0 (da) |
FR (1) | FR2534487B1 (da) |
GR (1) | GR79616B (da) |
HK (1) | HK49988A (da) |
IL (1) | IL69911A0 (da) |
Families Citing this family (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4753788A (en) * | 1985-01-31 | 1988-06-28 | Vestar Research Inc. | Method for preparing small vesicles using microemulsification |
FR2591105B1 (fr) | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide. |
AU598002B2 (en) * | 1986-07-15 | 1990-06-14 | Cilag Ltd. | Method of preparing single bilayered liposomes |
ATE115403T1 (de) * | 1987-01-27 | 1994-12-15 | Vestar Inc | Aus phospholipiden bestehende darreichungsform für wasserunlösliche wirksubstanzen. |
JPS63209746A (ja) * | 1987-02-27 | 1988-08-31 | Terumo Corp | リポソ−ムの製法 |
JP2599390B2 (ja) * | 1987-06-25 | 1997-04-09 | 第一製薬株式会社 | 安定なリポソーム水分散液 |
US5290562A (en) * | 1987-11-27 | 1994-03-01 | L V M H Recherche | Compositions and methods employing liposomes including tyrosine or a tyrosine derivative |
FR2623716B1 (fr) * | 1987-11-27 | 1991-04-05 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant |
CH675967A5 (da) * | 1987-12-09 | 1990-11-30 | Induchem Ag | |
US4895452A (en) * | 1988-03-03 | 1990-01-23 | Micro-Pak, Inc. | Method and apparatus for producing lipid vesicles |
DE3905354C2 (de) * | 1989-02-22 | 2000-02-10 | Reinhold A Brunke | Vorrichtung zum Zerkleinern von Liposomen |
FR2649335B1 (fr) * | 1989-07-05 | 1991-09-20 | Texinfine Sa | Procede et dispositif de production directe de liposomes |
WO1991004014A1 (en) * | 1989-09-21 | 1991-04-04 | Synergen, Inc. | Method for transporting compositions across the blood brain barrier |
US5469854A (en) * | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
US6146657A (en) | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
US6551576B1 (en) | 1989-12-22 | 2003-04-22 | Bristol-Myers Squibb Medical Imaging, Inc. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US5334381A (en) * | 1989-12-22 | 1994-08-02 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US6001335A (en) | 1989-12-22 | 1999-12-14 | Imarx Pharmaceutical Corp. | Contrasting agents for ultrasonic imaging and methods for preparing the same |
US5705187A (en) | 1989-12-22 | 1998-01-06 | Imarx Pharmaceutical Corp. | Compositions of lipids and stabilizing materials |
US20020150539A1 (en) | 1989-12-22 | 2002-10-17 | Unger Evan C. | Ultrasound imaging and treatment |
US5088499A (en) * | 1989-12-22 | 1992-02-18 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5773024A (en) | 1989-12-22 | 1998-06-30 | Imarx Pharmaceutical Corp. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US5305757A (en) | 1989-12-22 | 1994-04-26 | Unger Evan C | Gas filled liposomes and their use as ultrasonic contrast agents |
US6088613A (en) | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US5733572A (en) | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
US5776429A (en) | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
US5352435A (en) * | 1989-12-22 | 1994-10-04 | Unger Evan C | Ionophore containing liposomes for ultrasound imaging |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5656211A (en) | 1989-12-22 | 1997-08-12 | Imarx Pharmaceutical Corp. | Apparatus and method for making gas-filled vesicles of optimal size |
US5922304A (en) | 1989-12-22 | 1999-07-13 | Imarx Pharmaceutical Corp. | Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
EP0461333B1 (en) * | 1990-06-11 | 1995-03-29 | Idi Farmaceutici S.P.A. | Phospholipidic liposomes containing active principles and a process for the production thereof |
JPH04107319U (ja) * | 1991-02-26 | 1992-09-16 | 大日本プラスチツクス株式会社 | 外装材取付構造 |
FR2673840A1 (fr) * | 1991-03-14 | 1992-09-18 | Lvmh Rech | Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant de l'oxyacanthine, en particulier destinee a stimuler la pousse des cheveux ou a retarder leur chute. |
US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
US5874062A (en) | 1991-04-05 | 1999-02-23 | Imarx Pharmaceutical Corp. | Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents |
WO1993000156A1 (en) * | 1991-06-29 | 1993-01-07 | Miyazaki-Ken | Monodisperse single and double emulsions and production thereof |
FR2695035A1 (fr) * | 1992-08-25 | 1994-03-04 | Lvmh Rech Gie | Utilisation d'un ecdystéroïde pour la préparation de compositions cosmétiques ou dermatologiques destinées notamment à renforcer la fonction protectrice de la peau, et compositions ainsi obtenues. |
AU3244393A (en) * | 1992-12-02 | 1994-06-22 | Vestar, Inc. | Antibiotic formulation and process |
US5958449A (en) * | 1992-12-02 | 1999-09-28 | Nexstar Pharmaceuticals, Inc. | Antibiotic formulation and use for bacterial infections |
FR2699081B1 (fr) * | 1992-12-11 | 1995-04-07 | Lvmh Rech | Utilisation d'un extrait de Simaba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue. |
FR2699080B1 (fr) | 1992-12-11 | 1995-04-07 | Lvmh Rech | Utilisation d'un extrait de Simarouba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue. |
DE4309971A1 (de) * | 1993-03-26 | 1994-09-29 | Bayer Ag | Imprägnierungsemulsion für mineralische Baustoffe |
US5759571A (en) * | 1993-05-11 | 1998-06-02 | Nexstar Pharmaceuticals, Inc. | Antibiotic formulation and use for drug resistant infections |
US5492648A (en) * | 1993-07-02 | 1996-02-20 | Lau; John R. | Organic oil stabilization techniques |
US7083572B2 (en) | 1993-11-30 | 2006-08-01 | Bristol-Myers Squibb Medical Imaging, Inc. | Therapeutic delivery systems |
US5736121A (en) | 1994-05-23 | 1998-04-07 | Imarx Pharmaceutical Corp. | Stabilized homogenous suspensions as computed tomography contrast agents |
US5843334A (en) * | 1994-06-20 | 1998-12-01 | Nippon Shinyaku Co., Ltd. | Method of producing emulsions and an emulsification apparatus |
JP2976526B2 (ja) * | 1994-06-20 | 1999-11-10 | 日本新薬株式会社 | 乳剤の製法及び乳化機 |
US7196055B2 (en) | 1994-08-31 | 2007-03-27 | Trustees Of Boston University | Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor |
US6867179B1 (en) | 1994-08-31 | 2005-03-15 | Trustees Of Boston University | Methods of inducing hair growth and coloration |
US6743779B1 (en) | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5830430A (en) | 1995-02-21 | 1998-11-03 | Imarx Pharmaceutical Corp. | Cationic lipids and the use thereof |
US5997898A (en) | 1995-06-06 | 1999-12-07 | Imarx Pharmaceutical Corp. | Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery |
US20030032610A1 (en) * | 1996-06-03 | 2003-02-13 | Gilchrest Barbara A. | Method to inhibit cell growth using oligonucleotides |
US6147056A (en) * | 1995-06-06 | 2000-11-14 | Trustees Of Boston University | Use of locally applied DNA fragments |
WO2001074342A2 (en) * | 2000-03-31 | 2001-10-11 | Trustees Of Boston University | Use of locally applied dna fragments |
US7094766B1 (en) | 1995-06-06 | 2006-08-22 | Trustees Of Boston University | Use of locally applied DNA fragments |
US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6231834B1 (en) | 1995-06-07 | 2001-05-15 | Imarx Pharmaceutical Corp. | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
US6033645A (en) | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
NL1001380C2 (nl) * | 1995-10-09 | 1997-04-11 | Fuji Photo Film Bv | Methode voor het dispergeren van een geëmulgeerd materiaal van het olie-druppeltype in een vloeistoftoevoersysteem en bekledingsmethode waarbij van een dergelijke dispergeermethode gebruik wordt gemaakt. |
ATE405664T1 (de) * | 1996-03-28 | 2008-09-15 | Univ Boston | Methoden zur modulation der melaninsynthese |
DE69736981D1 (de) | 1996-05-01 | 2007-01-04 | Imarx Pharmaceutical Corp | In vitro verfahren zum einbringen von nukleinsäuren in eine zelle |
US6414139B1 (en) | 1996-09-03 | 2002-07-02 | Imarx Therapeutics, Inc. | Silicon amphiphilic compounds and the use thereof |
US5846517A (en) | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
PT977597E (pt) | 1996-09-11 | 2003-06-30 | Imarx Pharmaceutical Corp | Metodos melhorados para imagiologia de diagnosticoutilizando um agente de contraste e um vasodil atador |
ES2134130B1 (es) * | 1997-02-05 | 2000-04-16 | Inst Cientifico Tecnol Navarra | Procedimiento y aparato para la produccion de vectores no biologicos de transporte de sustancias por inyeccion coaxial turbulenta. |
US6537246B1 (en) | 1997-06-18 | 2003-03-25 | Imarx Therapeutics, Inc. | Oxygen delivery agents and uses for the same |
US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
US6143276A (en) | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
US7452551B1 (en) | 2000-10-30 | 2008-11-18 | Imarx Therapeutics, Inc. | Targeted compositions for diagnostic and therapeutic use |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6548047B1 (en) | 1997-09-15 | 2003-04-15 | Bristol-Myers Squibb Medical Imaging, Inc. | Thermal preactivation of gaseous precursor filled compositions |
US6123923A (en) | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
ATE261336T1 (de) * | 1998-12-07 | 2004-03-15 | Hoffmann La Roche | Verfahren und vorrichtung zum mischen oder dispergieren von flüssigkeiten |
US20060093661A1 (en) | 2002-05-07 | 2006-05-04 | Kapac, Llc | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
US20030212046A1 (en) * | 2002-05-07 | 2003-11-13 | Kapac, Llc | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
EA200200925A1 (ru) * | 2002-07-18 | 2003-04-24 | Ооо "Био-3" | Способ получения вододисперсионных препаратов жирорастворимых витаминов и антиоксидантов |
US20060269924A1 (en) * | 2003-04-11 | 2006-11-30 | Trustees Of Boston University | Modulation of telomere-initiated cell signaling |
CA2546583A1 (en) * | 2003-11-20 | 2005-06-09 | Zomanex, Llc | Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone |
FR2864539B1 (fr) * | 2003-12-30 | 2012-10-26 | Lvmh Rech | Oligonucleotide et son utilisation pour moduler l'expression de la proteine-kinase c isoforme beta-1 comme agent de depigmentation cutanee |
JP2007537758A (ja) | 2004-05-19 | 2007-12-27 | トラスティーズ オブ ボストン ユニバーシティ | Wrn媒介性テロメア開始型細胞シグナル伝達の調節 |
ATE431740T1 (de) * | 2004-12-22 | 2009-06-15 | Merck Serono Sa | Kombinationstherapie gegen multiple sklerose |
US8007790B2 (en) | 2006-04-03 | 2011-08-30 | Stowers Institute For Medical Research | Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases |
US20080124387A1 (en) | 2006-11-27 | 2008-05-29 | Kapac, Llc | Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
US20080207711A1 (en) * | 2007-02-28 | 2008-08-28 | Rong Li | Method for treating an ID2-related disorder |
CH715456B1 (de) * | 2007-04-27 | 2020-04-30 | Mibelle Ag | Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet. |
US20090088393A1 (en) * | 2007-09-28 | 2009-04-02 | Zomanex, Llc | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
ME00996B (me) | 2007-10-16 | 2012-10-20 | Repros Therapeutics Inc | Trans-klomifen za liječenje metaboličkog sindroma |
US8101606B2 (en) * | 2007-11-12 | 2012-01-24 | Washington University | Neurofibromin pathway modulators |
TWI477276B (zh) | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
CA2675704C (en) | 2009-08-18 | 2010-05-25 | The Procter & Gamble Company | A method of making a fabric softening composition using a dynamic orifice with a valve in different positions |
US8173589B2 (en) * | 2010-03-18 | 2012-05-08 | The Procter & Gamble Company | Low energy methods of making pearlescent fabric softener compositions |
SG10201504913UA (en) | 2010-03-22 | 2015-07-30 | Repros Therapeutics Inc | Compositions and methods for non-toxic delivery of antiprogestins |
UA113283C2 (xx) | 2010-12-23 | 2017-01-10 | 19-норстероїди і їх застосування для лікування прогестеронзалежних станів | |
US20130084326A1 (en) * | 2011-10-03 | 2013-04-04 | Bruce Howe | Liposomes for the oral delivery of therapeutic agents |
IN2014DN10548A (da) | 2012-05-31 | 2015-08-21 | Repros Therapeutics Inc | |
US9545411B2 (en) | 2012-11-02 | 2017-01-17 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
EP3124609A1 (en) | 2015-07-29 | 2017-02-01 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutics oligonucleotides |
EP3650546A1 (en) | 2015-07-29 | 2020-05-13 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutic oligonucleotides |
US12053748B2 (en) | 2018-06-14 | 2024-08-06 | Tetra Laval Holdings & Finance S.A. | Homogenizer for liquid food |
WO2020023340A1 (en) | 2018-07-23 | 2020-01-30 | Signalrx Pharmaceuticals, Inc. | Single molecule compounds providing multi-target inhibition of btk and other proteins and methods of use thereof |
WO2020055946A1 (en) | 2018-09-12 | 2020-03-19 | The Broad Institute, Inc. | Targeting egln1 in cancer |
EP4050002A1 (en) | 2021-02-26 | 2022-08-31 | First Health Pharmaceuticals B.V. | Anti-proliferative agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH366518A (de) * | 1959-01-15 | 1963-01-15 | Lendi Wilhelm | Homogenisiervorrichtung |
JPS5186117A (en) * | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4263428A (en) * | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
JPS55140359U (da) * | 1979-03-29 | 1980-10-07 |
-
1982
- 1982-10-15 FR FR8217311A patent/FR2534487B1/fr not_active Expired
-
1983
- 1983-10-05 IL IL69911A patent/IL69911A0/xx unknown
- 1983-10-06 EP EP83401954A patent/EP0107559B2/fr not_active Expired - Lifetime
- 1983-10-06 AT AT83401954T patent/ATE27909T1/de not_active IP Right Cessation
- 1983-10-06 DE DE8383401954T patent/DE3372174D1/de not_active Expired
- 1983-10-06 DE DE198383401954T patent/DE107559T1/de active Pending
- 1983-10-07 GR GR72692A patent/GR79616B/el unknown
- 1983-10-07 CA CA000438664A patent/CA1228779A/en not_active Expired
- 1983-10-13 US US06/541,426 patent/US4621023A/en not_active Expired - Lifetime
- 1983-10-14 ES ES526498A patent/ES526498A0/es active Granted
- 1983-10-14 DK DK475483A patent/DK159194C/da not_active IP Right Cessation
- 1983-10-15 JP JP58193331A patent/JPS5989620A/ja active Granted
-
1988
- 1988-07-07 HK HK499/88A patent/HK49988A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK49988A (en) | 1988-07-15 |
DK159194B (da) | 1990-09-17 |
ES8405638A1 (es) | 1984-06-16 |
EP0107559A1 (fr) | 1984-05-02 |
EP0107559B1 (fr) | 1987-06-24 |
ATE27909T1 (de) | 1987-07-15 |
DE3372174D1 (en) | 1987-07-30 |
EP0107559B2 (fr) | 1997-12-17 |
FR2534487B1 (fr) | 1988-06-10 |
DK475483A (da) | 1984-04-16 |
CA1228779A (en) | 1987-11-03 |
IL69911A0 (en) | 1984-01-31 |
DE107559T1 (de) | 1985-04-25 |
JPS5989620A (ja) | 1984-05-23 |
US4621023A (en) | 1986-11-04 |
ES526498A0 (es) | 1984-06-16 |
FR2534487A1 (fr) | 1984-04-20 |
DK159194C (da) | 1991-02-25 |
GR79616B (da) | 1984-10-31 |
JPH0131414B2 (da) | 1989-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK475483A (da) | Hydratiserede, lagdelte lipidfaser samt fremgangsmaade til fremstilling af en homogeniseret suspension heraf | |
AU3703095A (en) | Method and apparatus for diffusive transfer between immiscible fluids | |
NO954756D0 (no) | Fremgangsmåte og apparatur for fremstilling av liposomer | |
KR950007831A (ko) | 세라미드와 리놀렌산을 혼합한 신규 화장제 및 피부학적 조성물, 및 그의 제법 | |
DE69528077D1 (de) | Verfahren zur Herstellung von Liposomen, die hydrophobische Artzneistoffe enthalten | |
FR2521565B1 (fr) | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees | |
DE69508598D1 (de) | Mit polyethylenglycol modifizierte ceramidlipide und liposomen | |
ATE141780T1 (de) | Öl in wasser emulsionen verwendbar für die herstellung von einer creme | |
DE69500077D1 (de) | Kosmetische und dermatologische Zusammensetzung bestehend aus einem öligen Kügelchen und mit lamellaren Flüssigkristallen beschichtete Öl in Wasser Emulsion | |
ATE8743T1 (de) | Verfahren zur herstellung von strukturen aus lipoiden membranen. | |
EP0284026A3 (en) | Process for preparing emulsified fat composition | |
ES467222A1 (es) | Procedimiento de preparacion de una emulsion del tipo agua en aceite o aceite en agua estable. | |
NO994786D0 (no) | Olje-i-vann-emulsjoner for rekonstituering av lamellæriteten i lipidstrukturen i skadet hud | |
ES2149920T3 (es) | Emulsiones de aceite-en-agua estables al calor estabilizadas mediante hidrolizados. | |
PL320734A1 (en) | Novel emulsifiers, their production and application of theam in production of cosmetic and pharmaceutic preparations | |
DK0629128T3 (da) | Vandig phospholipidvesikeldispersion, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
KR900000074A (ko) | 초미세 리포좀 형태의 양쪽친화성 지질의 분산 콜로이드계를 제조하는 방법 | |
ES2059075T3 (es) | Composicion cosmetica o dermofarmaceutica que contiene vesiculas formadas por una mezcla de fosfolipidos y glicolipidos. | |
IL107471A (en) | Pharmaceutical preparation comprising a self- emulsifying formulation and process for its production | |
FR2681247B1 (fr) | Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation. | |
ATE59133T1 (de) | Verfahren zur herstellung von dispersionen mit zusammenhaengender lipider phase. | |
DE202021101684U1 (de) | Produktverpackung mit einem Aufhängeloch | |
FI77778B (fi) | Kosmetiskt medel innehaollande en dubbelemulsion och foerfarande foer dess framstaellning. | |
Nakamura et al. | Estimation of double layers flow model for fluidity of milk in a capillary | |
AR035473A1 (es) | Proceso para estabilizacion de emulsiones de agua en aceite, composicion topica cosmetica de emulsion de agua en aceite y proceso para la fabricacion de composicion topica cosmetica de emulsion de agua en aceite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |